|
EP0649651B1
(en)
*
|
1993-09-28 |
2000-12-13 |
R.P. Scherer GmbH |
Soft gelatin capsule manufacture
|
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
|
US6239124B1
(en)
*
|
1996-07-30 |
2001-05-29 |
Novartis Ag |
Pharmaceutical compositions for the treatment of transplant rejection or autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxyethyl)-rapamycin
|
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
US20030129215A1
(en)
*
|
1998-09-24 |
2003-07-10 |
T-Ram, Inc. |
Medical devices containing rapamycin analogs
|
|
US6890546B2
(en)
*
|
1998-09-24 |
2005-05-10 |
Abbott Laboratories |
Medical devices containing rapamycin analogs
|
|
GB9825632D0
(en)
*
|
1998-11-23 |
1999-01-13 |
Novartis Ag |
Organic compounds
|
|
GB9826882D0
(en)
*
|
1998-12-07 |
1999-01-27 |
Novartis Ag |
Organic compounds
|
|
US20020006901A1
(en)
|
1999-02-05 |
2002-01-17 |
Aldo T. Iacono |
Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
|
|
ATE474590T1
(de)
*
|
1999-05-10 |
2010-08-15 |
Paolo Brenner |
Kombination von immunsuppressiven substanzen zur behandlung oder vorbeugung von transplantat abstossungen
|
|
WO2002036606A1
(en)
*
|
2000-11-03 |
2002-05-10 |
Matrix Therapeutics Limited |
Selective glucocorticoid receptor agonists
|
|
US20020127263A1
(en)
*
|
2001-02-27 |
2002-09-12 |
Wenda Carlyle |
Peroxisome proliferator-acitvated receptor gamma ligand eluting medical device
|
|
US8741378B1
(en)
|
2001-06-27 |
2014-06-03 |
Advanced Cardiovascular Systems, Inc. |
Methods of coating an implantable device
|
|
US20040137066A1
(en)
*
|
2001-11-26 |
2004-07-15 |
Swaminathan Jayaraman |
Rationally designed therapeutic intravascular implant coating
|
|
US6641611B2
(en)
*
|
2001-11-26 |
2003-11-04 |
Swaminathan Jayaraman |
Therapeutic coating for an intravascular implant
|
|
US20080145402A1
(en)
*
|
2001-09-10 |
2008-06-19 |
Abbott Cardiovascular Systems Inc. |
Medical Devices Containing Rapamycin Analogs
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
PT1435910E
(pt)
*
|
2001-10-19 |
2009-09-07 |
Isotechnika Inc |
Novos pré-concentrados de microemulsão de análogos da ciclosporina
|
|
US20030153536A1
(en)
*
|
2001-10-25 |
2003-08-14 |
Mitchell Glass |
Compounds and methods of treating transplant rejection
|
|
US6939376B2
(en)
*
|
2001-11-05 |
2005-09-06 |
Sun Biomedical, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
|
US7682387B2
(en)
|
2002-04-24 |
2010-03-23 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
|
US7109169B2
(en)
*
|
2002-06-28 |
2006-09-19 |
Hobai Ion A |
Method for treating heart failure by inhibiting the sarcolemmal sodium/calcium exchange
|
|
ES2544624T3
(es)
|
2002-07-16 |
2015-09-02 |
Buck Institute For Research On Aging |
Producción de policétidos
|
|
MXPA05002539A
(es)
*
|
2002-09-06 |
2005-06-17 |
Abbott Lab |
Dispositivo medico que tiene inhibidor de hidratacion.
|
|
WO2004027027A2
(en)
*
|
2002-09-18 |
2004-04-01 |
Trustees Of The University Of Pennsylvania |
Method of inhibiting choroidal neovascularization
|
|
US8202530B2
(en)
*
|
2002-09-27 |
2012-06-19 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible coatings for stents
|
|
AR043504A1
(es)
*
|
2003-03-17 |
2005-08-03 |
Novartis Ag |
Composiciones farmaceuticas que comprenden rapamicina para el tratamiento de enfermedades inflamatorias
|
|
US7160867B2
(en)
*
|
2003-05-16 |
2007-01-09 |
Isotechnika, Inc. |
Rapamycin carbohydrate derivatives
|
|
AU2004267909B2
(en)
*
|
2003-08-29 |
2008-12-18 |
Veloxis Pharmaceuticals, Inc. |
Modified release compositions comprising tacrolimus
|
|
AU2004274026A1
(en)
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Transscleral delivery
|
|
US20110104186A1
(en)
|
2004-06-24 |
2011-05-05 |
Nicholas Valiante |
Small molecule immunopotentiators and assays for their detection
|
|
US8709469B2
(en)
|
2004-06-30 |
2014-04-29 |
Abbott Cardiovascular Systems Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
|
GB0417852D0
(en)
|
2004-08-11 |
2004-09-15 |
Biotica Tech Ltd |
Production of polyketides and other natural products
|
|
US8021849B2
(en)
*
|
2004-11-05 |
2011-09-20 |
Siemens Healthcare Diagnostics Inc. |
Methods and kits for the determination of sirolimus in a sample
|
|
CA2597590A1
(en)
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Formulations for ocular treatment
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
KR20070104908A
(ko)
*
|
2005-02-15 |
2007-10-29 |
와이어쓰 |
경구적으로 생체이용가능한 ｃｃｉ-779 정제 제형물
|
|
NZ595313A
(en)
|
2005-02-18 |
2013-03-28 |
Abraxis Bioscience Llc |
The Use Of Nanoparticles Comprising Rapamycin Or Taxane In The Treatment Of Proliferative Diseases
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
GB0504994D0
(en)
|
2005-03-11 |
2005-04-20 |
Biotica Tech Ltd |
Novel compounds
|
|
AU2006221774A1
(en)
|
2005-03-11 |
2006-09-14 |
Biotica Technology Limited |
Medical uses of 39-desmethoxyrapamycin and analogues thereof
|
|
AU2006227116A1
(en)
*
|
2005-03-21 |
2006-09-28 |
Santen Pharmaceutical Co., Ltd. |
Drug delivery systems for treatment of diseases or conditions
|
|
WO2006110802A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cyclosporine
|
|
US7189582B2
(en)
*
|
2005-04-27 |
2007-03-13 |
Dade Behring Inc. |
Compositions and methods for detection of sirolimus
|
|
EP1879632A2
(en)
*
|
2005-04-29 |
2008-01-23 |
Atrium Medical Corporation |
Drug delivery coating for use with a medical device and methods of treating vascular injury
|
|
US20080020040A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Horizon Therapeutics, Inc. |
Unit dose form for administration of ibuprofen
|
|
US20070043097A1
(en)
*
|
2005-07-18 |
2007-02-22 |
Horizon Therapeutics, Inc. |
Medicaments containing famotidine and ibuprofen and administration of same
|
|
US8067451B2
(en)
|
2006-07-18 |
2011-11-29 |
Horizon Pharma Usa, Inc. |
Methods and medicaments for administration of ibuprofen
|
|
US20080021078A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Horizon Therapeutics, Inc. |
Methods and medicaments for administration of ibuprofen
|
|
WO2007092620A2
(en)
|
2006-02-09 |
2007-08-16 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
|
US8222271B2
(en)
|
2006-03-23 |
2012-07-17 |
Santen Pharmaceutical Co., Ltd. |
Formulations and methods for vascular permeability-related diseases or conditions
|
|
US8067033B2
(en)
|
2007-11-30 |
2011-11-29 |
Horizon Pharma Usa, Inc. |
Stable compositions of famotidine and ibuprofen
|
|
EP2063873A2
(en)
*
|
2006-08-31 |
2009-06-03 |
Horizon Therapeutics, Inc. |
Nsaid dose unit formulations with h2-receptor antagonists and methods of use
|
|
US8661630B2
(en)
|
2008-05-21 |
2014-03-04 |
Abbott Cardiovascular Systems Inc. |
Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer
|
|
DE102008060549A1
(de)
|
2008-12-04 |
2010-06-10 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
|
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
|
BR112012024590A2
(pt)
|
2010-03-29 |
2016-05-31 |
Abraxis Bioscience Inc |
métodos de reforço da liberação de fármaco e da eficácia de agentes terapêuticos
|
|
RU2016119999A
(ru)
|
2010-03-29 |
2018-11-08 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Способы лечения онкологических заболеваний
|
|
US8685433B2
(en)
|
2010-03-31 |
2014-04-01 |
Abbott Cardiovascular Systems Inc. |
Absorbable coating for implantable device
|
|
JP6257324B2
(ja)
|
2010-06-04 |
2018-01-10 |
アブラクシス バイオサイエンス， エルエルシー |
膵臓がんの処置方法
|
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
|
AU2012211809A1
(en)
*
|
2011-01-31 |
2013-09-05 |
Osaka University |
Externally-used drug for treating skin disorder and method for producing same
|
|
WO2012170384A1
(en)
|
2011-06-06 |
2012-12-13 |
Chevron Phillips Chemical Company Lp |
Use of metallocene compounds for cancer treatment
|
|
GB201122305D0
(en)
|
2011-12-23 |
2012-02-01 |
Biotica Tech Ltd |
Novel compound
|
|
US9220759B2
(en)
|
2012-02-23 |
2015-12-29 |
Abbott Cardiovascular Systems Inc. |
Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
|
|
US9220584B2
(en)
|
2012-03-30 |
2015-12-29 |
Abbott Cardiovascular Systems Inc. |
Treatment of diabetic patients with a stent and locally administered adjunctive therapy
|
|
EP2705856A1
(en)
|
2012-09-07 |
2014-03-12 |
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. |
Compounds for the treatment of neurodegenerative disorders
|
|
DK2948134T3
(da)
|
2013-01-24 |
2020-06-02 |
Palvella Therapeutics Inc |
Sammensætninger til transdermal indgivelse af mtor-inhibitorer
|
|
JP6749239B2
(ja)
|
2013-09-24 |
2020-09-02 |
ガイナー ライフ サイエンシズ，インク． |
細胞インプラントのガス処理用システム
|
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
|
US20160361322A1
(en)
|
2015-06-15 |
2016-12-15 |
Lipocine Inc. |
Composition and method for oral delivery of androgen prodrugs
|
|
EP3371590A4
(en)
*
|
2015-11-06 |
2019-07-10 |
The Trustees of Columbia University in the City of New York |
EXOSOMAL PROTEIN PROFILING FOR THE DETECTION OF HEART TRANSPLANT DISCHARGE
|
|
EP3541449B1
(en)
|
2016-11-15 |
2021-11-10 |
Giner Life Sciences, Inc. |
Percutaneous gas diffusion device suitable for use with a subcutaneous implant
|
|
US11559530B2
(en)
|
2016-11-28 |
2023-01-24 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
|
CN110520097B
(zh)
|
2017-01-06 |
2023-10-27 |
帕尔维拉治疗股份有限公司 |
Mtor抑制剂的无水组合物及其使用方法
|
|
JP2020507632A
(ja)
|
2017-02-10 |
2020-03-12 |
マウント タム セラピューティクス, インコーポレイテッドMount Tam Therapeutics, Inc. |
ラパマイシン類似体
|
|
US11642501B2
(en)
|
2017-05-04 |
2023-05-09 |
Giner, Inc. |
Robust, implantable gas delivery device and methods, systems and devices including same
|
|
JP2021530463A
(ja)
|
2018-07-02 |
2021-11-11 |
パルヴェラ セラピューティクス、インク． |
ｍＴＯＲ阻害剤の無水組成物および使用方法
|
|
EP3824296A4
(en)
|
2018-07-20 |
2022-04-27 |
Lipocine Inc. |
LIVER DISEASE
|